APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastro-retentive Drug Delivery System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gastro-retentive Drug Delivery System Market Outlook and Growth Opportunities 2026

3 May 2026192 pages

Choose your research edition.

Industry ResearchGastro-retentive Drug Delivery System Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastro-retentive Drug Delivery System Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Gastro-retentive Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastro-retentive Drug Delivery System Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastro-retentive Drug Delivery System Market Analysis and Forecast 2026-2032253 pages · $4,950 USD

Market perspective

The global Gastro-retentive Drug Delivery System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gastro-retentive Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastro-retentive Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastro-retentive Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gastro-retentive Drug Delivery System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gastro-retentive Drug Delivery System market include Triastek, Inc., Bostal Drug Delivery Co., Ltd., Vivtex Corporation, Clexio Biosciences Ltd., Medimetrics Personalized Drug Delivery, Inc., Lonza Group AG, Catalent, Inc., Evonik Industries AG and Colorcon, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Gastro-retentive Drug Delivery System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastro-retentive Drug Delivery System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastro-retentive Drug Delivery System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gastro-retentive Drug Delivery System market.

Gastro-retentive Drug Delivery System Segment by Company

Triastek, Inc.

Bostal Drug Delivery Co., Ltd.

Vivtex Corporation

Clexio Biosciences Ltd.

Medimetrics Personalized Drug Delivery, Inc.

Lonza Group AG

Catalent, Inc.

Evonik Industries AG

Colorcon, Inc.

Quotient Sciences

AbbVie Inc.

AstraZeneca plc

GlaxoSmithKline plc (GSK)

Novartis AG

Pfizer Inc.

Sanofi S.A.

Sun Pharmaceutical Industries Ltd.

Lupin Limited

Dr. Reddy's Laboratories Ltd.

Cipla Ltd.

Gastro-retentive Drug Delivery System Segment by Type

Sustained Release

Controlled Release (Zero-Order)

Delayed / Pulsatile Release

Gastro-retentive Drug Delivery System Segment by Application

Anti-infective (H. pylori Eradication)

Gastroenterology (Peptic Ulcer, GERD)

Metabolic Disorders (Diabetes)

Cardiovascular (Hypertension)

Antiviral Therapy

Gastro-retentive Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gastro-retentive Drug Delivery System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Gastro-retentive Drug Delivery System key companies, revenue, market share, and recent developments.

3. To split the Gastro-retentive Drug Delivery System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Gastro-retentive Drug Delivery System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gastro-retentive Drug Delivery System significant trends, drivers, influence factors in global and regions.

6. To analyze Gastro-retentive Drug Delivery System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastro-retentive Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastro-retentive Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastro-retentive Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastro-retentive Drug Delivery System industry.

Chapter 3: Detailed analysis of Gastro-retentive Drug Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Gastro-retentive Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Gastro-retentive Drug Delivery System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gastro-retentive Drug Delivery System Industry Trends Table 2. Gastro-retentive Drug Delivery System Industry Drivers Table 3. Gastro-retentive Drug Delivery System Industry Opportunities and Challenges Table 4. Gastro-retentive Drug Delivery System Industry Restraints Table 5. Global Gastro-retentive Drug Delivery System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gastro-retentive Drug Delivery System Revenue Share by Company (2021-2026) Table 7. Global Gastro-retentive Drug Delivery System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Gastro-retentive Drug Delivery System Key Company Manufacturing Base & Headquarters Table 9. Global Gastro-retentive Drug Delivery System Company, Product Type & Application Table 10. Global Gastro-retentive Drug Delivery System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Gastro-retentive Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sustained Release Table 15. Significant Companies of Controlled Release (Zero-Order) Table 16. Significant Companies of Delayed / Pulsatile Release Table 17. Global Gastro-retentive Drug Delivery System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Gastro-retentive Drug Delivery System Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Gastro-retentive Drug Delivery System Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Gastro-retentive Drug Delivery System Sales Value Share by Type (2021-2026) Table 21. Global Gastro-retentive Drug Delivery System Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Anti-infective (H. pylori Eradication) Table 23. Significant Companies of Gastroenterology (Peptic Ulcer, GERD) Table 24. Significant Companies of Metabolic Disorders (Diabetes) Table 25. Significant Companies of Cardiovascular (Hypertension) Table 26. Significant Companies of Antiviral Therapy Table 27. Global Gastro-retentive Drug Delivery System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Gastro-retentive Drug Delivery System Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Gastro-retentive Drug Delivery System Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Gastro-retentive Drug Delivery System Sales Value Share by Application (2021-2026) Table 31. Global Gastro-retentive Drug Delivery System Sales Value Share by Application (2027-2032) Table 32. Global Gastro-retentive Drug Delivery System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Gastro-retentive Drug Delivery System Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Gastro-retentive Drug Delivery System Sales Value Share by Region (2021-2026) Table 35. Global Gastro-retentive Drug Delivery System Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Gastro-retentive Drug Delivery System Sales Value Share by Region (2027-2032) Table 37. Global Gastro-retentive Drug Delivery System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Gastro-retentive Drug Delivery System Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Gastro-retentive Drug Delivery System Sales Value Market Share by Country (2021-2026) Table 40. Global Gastro-retentive Drug Delivery System Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Gastro-retentive Drug Delivery System Sales Value Market Share by Country (2027-2032) Table 42. Triastek, Inc. Company Information Table 43. Triastek, Inc. Business Overview Table 44. Triastek, Inc. Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Triastek, Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 46. Triastek, Inc. Recent Development Table 47. Bostal Drug Delivery Co., Ltd. Company Information Table 48. Bostal Drug Delivery Co., Ltd. Business Overview Table 49. Bostal Drug Delivery Co., Ltd. Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Bostal Drug Delivery Co., Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 51. Bostal Drug Delivery Co., Ltd. Recent Development Table 52. Vivtex Corporation Company Information Table 53. Vivtex Corporation Business Overview Table 54. Vivtex Corporation Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Vivtex Corporation Gastro-retentive Drug Delivery System Product Portfolio Table 56. Vivtex Corporation Recent Development Table 57. Clexio Biosciences Ltd. Company Information Table 58. Clexio Biosciences Ltd. Business Overview Table 59. Clexio Biosciences Ltd. Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Clexio Biosciences Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 61. Clexio Biosciences Ltd. Recent Development Table 62. Medimetrics Personalized Drug Delivery, Inc. Company Information Table 63. Medimetrics Personalized Drug Delivery, Inc. Business Overview Table 64. Medimetrics Personalized Drug Delivery, Inc. Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Medimetrics Personalized Drug Delivery, Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 66. Medimetrics Personalized Drug Delivery, Inc. Recent Development Table 67. Lonza Group AG Company Information Table 68. Lonza Group AG Business Overview Table 69. Lonza Group AG Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lonza Group AG Gastro-retentive Drug Delivery System Product Portfolio Table 71. Lonza Group AG Recent Development Table 72. Catalent, Inc. Company Information Table 73. Catalent, Inc. Business Overview Table 74. Catalent, Inc. Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Catalent, Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 76. Catalent, Inc. Recent Development Table 77. Evonik Industries AG Company Information Table 78. Evonik Industries AG Business Overview Table 79. Evonik Industries AG Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Evonik Industries AG Gastro-retentive Drug Delivery System Product Portfolio Table 81. Evonik Industries AG Recent Development Table 82. Colorcon, Inc. Company Information Table 83. Colorcon, Inc. Business Overview Table 84. Colorcon, Inc. Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Colorcon, Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 86. Colorcon, Inc. Recent Development Table 87. Quotient Sciences Company Information Table 88. Quotient Sciences Business Overview Table 89. Quotient Sciences Gastro-retentive Drug Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Quotient Sciences Gastro-retentive Drug Delivery System Product Portfolio Table 91. Quotient Sciences Recent Development Table 92. AbbVie Inc. Company Information Table 93. AbbVie Inc. Business Overview Table 94. AbbVie Inc. Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. AbbVie Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 96. AbbVie Inc. Recent Development Table 97. AstraZeneca plc Company Information Table 98. AstraZeneca plc Business Overview Table 99. AstraZeneca plc Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. AstraZeneca plc Gastro-retentive Drug Delivery System Product Portfolio Table 101. AstraZeneca plc Recent Development Table 102. GlaxoSmithKline plc (GSK) Company Information Table 103. GlaxoSmithKline plc (GSK) Business Overview Table 104. GlaxoSmithKline plc (GSK) Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline plc (GSK) Gastro-retentive Drug Delivery System Product Portfolio Table 106. GlaxoSmithKline plc (GSK) Recent Development Table 107. Novartis AG Company Information Table 108. Novartis AG Business Overview Table 109. Novartis AG Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Novartis AG Gastro-retentive Drug Delivery System Product Portfolio Table 111. Novartis AG Recent Development Table 112. Pfizer Inc. Company Information Table 113. Pfizer Inc. Business Overview Table 114. Pfizer Inc. Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Pfizer Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 116. Pfizer Inc. Recent Development Table 117. Sanofi S.A. Company Information Table 118. Sanofi S.A. Business Overview Table 119. Sanofi S.A. Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Sanofi S.A. Gastro-retentive Drug Delivery System Product Portfolio Table 121. Sanofi S.A. Recent Development Table 122. Sun Pharmaceutical Industries Ltd. Company Information Table 123. Sun Pharmaceutical Industries Ltd. Business Overview Table 124. Sun Pharmaceutical Industries Ltd. Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Sun Pharmaceutical Industries Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 126. Sun Pharmaceutical Industries Ltd. Recent Development Table 127. Lupin Limited Company Information Table 128. Lupin Limited Business Overview Table 129. Lupin Limited Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Lupin Limited Gastro-retentive Drug Delivery System Product Portfolio Table 131. Lupin Limited Recent Development Table 132. Dr. Reddy's Laboratories Ltd. Company Information Table 133. Dr. Reddy's Laboratories Ltd. Business Overview Table 134. Dr. Reddy's Laboratories Ltd. Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Dr. Reddy's Laboratories Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 136. Dr. Reddy's Laboratories Ltd. Recent Development Table 137. Cipla Ltd. Company Information Table 138. Cipla Ltd. Business Overview Table 139. Cipla Ltd. Gastro-retentive Drug Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Cipla Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 141. Cipla Ltd. Recent Development Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Gastro-retentive Drug Delivery System Product Image Figure 2. Global Gastro-retentive Drug Delivery System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastro-retentive Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastro-retentive Drug Delivery System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sustained Release Image Figure 8. Controlled Release (Zero-Order) Image Figure 9. Delayed / Pulsatile Release Image Figure 10. Global Gastro-retentive Drug Delivery System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Gastro-retentive Drug Delivery System Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Gastro-retentive Drug Delivery System Sales Value Share by Type (2021-2032) Figure 13. Anti-infective (H. pylori Eradication) Image Figure 14. Gastroenterology (Peptic Ulcer, GERD) Image Figure 15. Metabolic Disorders (Diabetes) Image Figure 16. Cardiovascular (Hypertension) Image Figure 17. Antiviral Therapy Image Figure 18. Global Gastro-retentive Drug Delivery System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Gastro-retentive Drug Delivery System Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Gastro-retentive Drug Delivery System Sales Value Share by Application (2021-2032) Figure 21. Global Gastro-retentive Drug Delivery System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Gastro-retentive Drug Delivery System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Gastro-retentive Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 24. North America Gastro-retentive Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Gastro-retentive Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Gastro-retentive Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Gastro-retentive Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Gastro-retentive Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Gastro-retentive Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 30. South America Gastro-retentive Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Gastro-retentive Drug Delivery System Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Gastro-retentive Drug Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Sustained Release
  • Controlled Release (Zero-Order)
  • Delayed / Pulsatile Release
Applications
  • Anti-infective (H. pylori Eradication)
  • Gastroenterology (Peptic Ulcer, GERD)
  • Metabolic Disorders (Diabetes)
  • Cardiovascular (Hypertension)
  • Antiviral Therapy
Companies covered
  • Triastek, Inc.
  • Bostal Drug Delivery Co., Ltd.
  • Vivtex Corporation
  • Clexio Biosciences Ltd.
  • Medimetrics Personalized Drug Delivery, Inc.
  • Lonza Group AG
  • Catalent, Inc.
  • Evonik Industries AG
  • Colorcon, Inc.
  • Quotient Sciences
  • AbbVie Inc.
  • AstraZeneca plc
  • GlaxoSmithKline plc (GSK)
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gastro-retentive Drug Delivery System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gastro-retentive Drug Delivery System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Gastro-retentive Drug Delivery System Market Dynamics
  1. 2.1 Gastro-retentive Drug Delivery System Industry Trends
  2. 2.2 Gastro-retentive Drug Delivery System Industry Drivers
  3. 2.3 Gastro-retentive Drug Delivery System Industry Opportunities and Challenges
  4. 2.4 Gastro-retentive Drug Delivery System Industry Restraints
3 Gastro-retentive Drug Delivery System Market by Company
  1. 3.1 Global Gastro-retentive Drug Delivery System Company Revenue Ranking in 2025
  2. 3.2 Global Gastro-retentive Drug Delivery System Revenue by Company (2021-2026)
  3. 3.3 Global Gastro-retentive Drug Delivery System Company Ranking (2024-2026)
  4. 3.4 Global Gastro-retentive Drug Delivery System Company Manufacturing Base and Headquarters
  5. 3.5 Global Gastro-retentive Drug Delivery System Company Product Type and Application
  6. 3.6 Global Gastro-retentive Drug Delivery System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Gastro-retentive Drug Delivery System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Gastro-retentive Drug Delivery System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Gastro-retentive Drug Delivery System Market by Type
  1. 4.1 Gastro-retentive Drug Delivery System Type Introduction
  2. 4.1.1 Sustained Release
  3. 4.1.2 Controlled Release (Zero-Order)
  4. 4.1.3 Delayed / Pulsatile Release
  5. 4.2 Global Gastro-retentive Drug Delivery System Sales Value by Type
  6. 4.2.1 Global Gastro-retentive Drug Delivery System Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gastro-retentive Drug Delivery System Sales Value by Type (2021-2032)
  8. 4.2.3 Global Gastro-retentive Drug Delivery System Sales Value Share by Type (2021-2032)
5 Gastro-retentive Drug Delivery System Market by Application
  1. 5.1 Gastro-retentive Drug Delivery System Application Introduction
  2. 5.1.1 Anti-infective (H. pylori Eradication)
  3. 5.1.2 Gastroenterology (Peptic Ulcer, GERD)
  4. 5.1.3 Metabolic Disorders (Diabetes)
  5. 5.1.4 Cardiovascular (Hypertension)
  6. 5.1.5 Antiviral Therapy
  7. 5.2 Global Gastro-retentive Drug Delivery System Sales Value by Application
  8. 5.2.1 Global Gastro-retentive Drug Delivery System Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Gastro-retentive Drug Delivery System Sales Value by Application (2021-2032)
  10. 5.2.3 Global Gastro-retentive Drug Delivery System Sales Value Share by Application (2021-2032)
6 Gastro-retentive Drug Delivery System Regional Value Analysis
  1. 6.1 Global Gastro-retentive Drug Delivery System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastro-retentive Drug Delivery System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Gastro-retentive Drug Delivery System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Gastro-retentive Drug Delivery System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gastro-retentive Drug Delivery System Sales Value (2021-2032)
  7. 6.3.2 North America Gastro-retentive Drug Delivery System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Gastro-retentive Drug Delivery System Sales Value (2021-2032)
  10. 6.4.2 Europe Gastro-retentive Drug Delivery System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Gastro-retentive Drug Delivery System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Gastro-retentive Drug Delivery System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Gastro-retentive Drug Delivery System Sales Value (2021-2032)
  16. 6.6.2 South America Gastro-retentive Drug Delivery System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Gastro-retentive Drug Delivery System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Gastro-retentive Drug Delivery System Sales Value Share by Country, 2025 VS 2032
7 Gastro-retentive Drug Delivery System Country-level Value Analysis
  1. 7.1 Global Gastro-retentive Drug Delivery System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gastro-retentive Drug Delivery System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Gastro-retentive Drug Delivery System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Gastro-retentive Drug Delivery System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Gastro-retentive Drug Delivery System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Gastro-retentive Drug Delivery System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Gastro-retentive Drug Delivery System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Triastek, Inc.
  2. 8.1.1 Triastek, Inc. Company Information
  3. 8.1.2 Triastek, Inc. Business Overview
  4. 8.1.3 Triastek, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Triastek, Inc. Gastro-retentive Drug Delivery System Product Portfolio
  6. 8.1.5 Triastek, Inc. Recent Developments
  7. 8.2 Bostal Drug Delivery Co., Ltd.
  8. 8.2.1 Bostal Drug Delivery Co., Ltd. Company Information
  9. 8.2.2 Bostal Drug Delivery Co., Ltd. Business Overview
  10. 8.2.3 Bostal Drug Delivery Co., Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bostal Drug Delivery Co., Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  12. 8.2.5 Bostal Drug Delivery Co., Ltd. Recent Developments
  13. 8.3 Vivtex Corporation
  14. 8.3.1 Vivtex Corporation Company Information
  15. 8.3.2 Vivtex Corporation Business Overview
  16. 8.3.3 Vivtex Corporation Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vivtex Corporation Gastro-retentive Drug Delivery System Product Portfolio
  18. 8.3.5 Vivtex Corporation Recent Developments
  19. 8.4 Clexio Biosciences Ltd.
  20. 8.4.1 Clexio Biosciences Ltd. Company Information
  21. 8.4.2 Clexio Biosciences Ltd. Business Overview
  22. 8.4.3 Clexio Biosciences Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Clexio Biosciences Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  24. 8.4.5 Clexio Biosciences Ltd. Recent Developments
  25. 8.5 Medimetrics Personalized Drug Delivery, Inc.
  26. 8.5.1 Medimetrics Personalized Drug Delivery, Inc. Company Information
  27. 8.5.2 Medimetrics Personalized Drug Delivery, Inc. Business Overview
  28. 8.5.3 Medimetrics Personalized Drug Delivery, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Medimetrics Personalized Drug Delivery, Inc. Gastro-retentive Drug Delivery System Product Portfolio
  30. 8.5.5 Medimetrics Personalized Drug Delivery, Inc. Recent Developments
  31. 8.6 Lonza Group AG
  32. 8.6.1 Lonza Group AG Company Information
  33. 8.6.2 Lonza Group AG Business Overview
  34. 8.6.3 Lonza Group AG Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lonza Group AG Gastro-retentive Drug Delivery System Product Portfolio
  36. 8.6.5 Lonza Group AG Recent Developments
  37. 8.7 Catalent, Inc.
  38. 8.7.1 Catalent, Inc. Company Information
  39. 8.7.2 Catalent, Inc. Business Overview
  40. 8.7.3 Catalent, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Catalent, Inc. Gastro-retentive Drug Delivery System Product Portfolio
  42. 8.7.5 Catalent, Inc. Recent Developments
  43. 8.8 Evonik Industries AG
  44. 8.8.1 Evonik Industries AG Company Information
  45. 8.8.2 Evonik Industries AG Business Overview
  46. 8.8.3 Evonik Industries AG Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Evonik Industries AG Gastro-retentive Drug Delivery System Product Portfolio
  48. 8.8.5 Evonik Industries AG Recent Developments
  49. 8.9 Colorcon, Inc.
  50. 8.9.1 Colorcon, Inc. Company Information
  51. 8.9.2 Colorcon, Inc. Business Overview
  52. 8.9.3 Colorcon, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Colorcon, Inc. Gastro-retentive Drug Delivery System Product Portfolio
  54. 8.9.5 Colorcon, Inc. Recent Developments
  55. 8.10 Quotient Sciences
  56. 8.10.1 Quotient Sciences Company Information
  57. 8.10.2 Quotient Sciences Business Overview
  58. 8.10.3 Quotient Sciences Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Quotient Sciences Gastro-retentive Drug Delivery System Product Portfolio
  60. 8.10.5 Quotient Sciences Recent Developments
  61. 8.11 AbbVie Inc.
  62. 8.11.1 AbbVie Inc. Company Information
  63. 8.11.2 AbbVie Inc. Business Overview
  64. 8.11.3 AbbVie Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AbbVie Inc. Gastro-retentive Drug Delivery System Product Portfolio
  66. 8.11.5 AbbVie Inc. Recent Developments
  67. 8.12 AstraZeneca plc
  68. 8.12.1 AstraZeneca plc Company Information
  69. 8.12.2 AstraZeneca plc Business Overview
  70. 8.12.3 AstraZeneca plc Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca plc Gastro-retentive Drug Delivery System Product Portfolio
  72. 8.12.5 AstraZeneca plc Recent Developments
  73. 8.13 GlaxoSmithKline plc (GSK)
  74. 8.13.1 GlaxoSmithKline plc (GSK) Company Information
  75. 8.13.2 GlaxoSmithKline plc (GSK) Business Overview
  76. 8.13.3 GlaxoSmithKline plc (GSK) Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  77. 8.13.4 GlaxoSmithKline plc (GSK) Gastro-retentive Drug Delivery System Product Portfolio
  78. 8.13.5 GlaxoSmithKline plc (GSK) Recent Developments
  79. 8.14 Novartis AG
  80. 8.14.1 Novartis AG Company Information
  81. 8.14.2 Novartis AG Business Overview
  82. 8.14.3 Novartis AG Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novartis AG Gastro-retentive Drug Delivery System Product Portfolio
  84. 8.14.5 Novartis AG Recent Developments
  85. 8.15 Pfizer Inc.
  86. 8.15.1 Pfizer Inc. Company Information
  87. 8.15.2 Pfizer Inc. Business Overview
  88. 8.15.3 Pfizer Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Pfizer Inc. Gastro-retentive Drug Delivery System Product Portfolio
  90. 8.15.5 Pfizer Inc. Recent Developments
  91. 8.16 Sanofi S.A.
  92. 8.16.1 Sanofi S.A. Company Information
  93. 8.16.2 Sanofi S.A. Business Overview
  94. 8.16.3 Sanofi S.A. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sanofi S.A. Gastro-retentive Drug Delivery System Product Portfolio
  96. 8.16.5 Sanofi S.A. Recent Developments
  97. 8.17 Sun Pharmaceutical Industries Ltd.
  98. 8.17.1 Sun Pharmaceutical Industries Ltd. Company Information
  99. 8.17.2 Sun Pharmaceutical Industries Ltd. Business Overview
  100. 8.17.3 Sun Pharmaceutical Industries Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sun Pharmaceutical Industries Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  102. 8.17.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  103. 8.18 Lupin Limited
  104. 8.18.1 Lupin Limited Company Information
  105. 8.18.2 Lupin Limited Business Overview
  106. 8.18.3 Lupin Limited Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Lupin Limited Gastro-retentive Drug Delivery System Product Portfolio
  108. 8.18.5 Lupin Limited Recent Developments
  109. 8.19 Dr. Reddy's Laboratories Ltd.
  110. 8.19.1 Dr. Reddy's Laboratories Ltd. Company Information
  111. 8.19.2 Dr. Reddy's Laboratories Ltd. Business Overview
  112. 8.19.3 Dr. Reddy's Laboratories Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Dr. Reddy's Laboratories Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  114. 8.19.5 Dr. Reddy's Laboratories Ltd. Recent Developments
  115. 8.20 Cipla Ltd.
  116. 8.20.1 Cipla Ltd. Company Information
  117. 8.20.2 Cipla Ltd. Business Overview
  118. 8.20.3 Cipla Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Cipla Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  120. 8.20.5 Cipla Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst